Brain iron metabolism and neurodegenerative disorders

Developmental Neuroscience

Volumn 24, Issue 2-3, 2002, Pages 188-196

  Sipe, Jack C ^a   Lee, Pauline ^a   Beutler, Ernest ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Gene; Iron; Metabolism; Mutation; Neurodegeneration; Single nucleotide polymorphism

Indexed keywords

M PROTEIN;

BRAIN DISEASE; BRAIN DYSFUNCTION; BRAIN METABOLISM; CENTRAL NERVOUS SYSTEM DISEASE; DEGENERATIVE DISEASE; GENE MUTATION; GENETIC CODE; HOMEOSTASIS; HUMAN; IRON BALANCE; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; MEDICAL ASSESSMENT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; BRAIN; HUMANS; IRON; NEURODEGENERATIVE DISEASES;

EID: 0036970185     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065701     Document Type: Review

References (111)

1. Lieu P, Heiskala M, Peterson P, Yang Y: The roles of iron in health and disease. Mol Aspects Med 2001;22:1-87.
2. Eisenstein R: Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr 2000;20:627-662.
3. Rouault T: Systemic iron metabolism: A review and implications for brain iron metabolism. Pediatr Neurol 2001;25:130-137.
4. D'Sa CM, Arthur RE Jr, States JC, Kuhn DM: Tryptophan hydroxylase: Cloning and expression of the rat brain enzyme in mammalian cells. J Neurochem 1996;67:900-906.
5. Connor JR, Menzies SL: Relationship of iron to oligodendrocytes and myelination. Glia 1996;17:83-93.
6. Connor JR, Pavlick G, Karli D, Menzies SL, Palmer C: A histochemical study of iron-positive cells in the developing rat brain. J Comp Neurol 1995;355:111-123.
7. Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ: Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res 1992;31:327-335.
8. Aoki S, Okada Y, Nishimura K, Barkovich A, Kjos B, Brasch R, Norman D: Normal deposition of brain iron in childhood and adolescence: MR imaging at 1.5 T. Radiology 1989;172:381-385.
9. Bartzokis G, Beckson M, Hance D, Marx P, Foster J, Marder S: MR evaluation of age-related increase of brain iron in young adult and older normal males. Magn Reson Imaging 1997;15:29-35.
10. Connor JR, Menzies SL, Burdo JR, Boyer PJ: Iron and iron management proteins in neurobiology. Pediatr Neurol 2001;25:118-129.
11. Beal MF: Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1998;1366:211-223.
12. Faucheux B, Hirsch E: Iron homeostasis and Parkinson's disease (in French). Ann Biol Clin (Paris) 1998;56(Spec No):23-30.
13. Beard JL, Dawson H, Pinero DJ: Iron metabolism: A comprehensive review. Nutr Rev 1996;54:295-317.
14. Rouault T, Klausner R: Regulation of iron metabolism in eukaryotes. Curr Top Cell Regul 1997;35:1-19.
15. Bothwell T: Overview and mechanisms of iron regulation. Nutr Rev 1995;53:237-245.
16. Morris CM, Candy JM, Keith AB, Oakley AE, Taylor GA, Pullen RG, Bloxham CA, Gocht A, Edwardson JA: Brain iron homeostasis. J Inorg Biochem 1992;47:257-265.
17. Bradbury MW: Transport of iron in the blood-brain-cerebrospinal fluid system. J Neurochem 1997;69:443-454.
18. Moos T: Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system. J Comp Neurol 1996;375:675-692.
19. Kawamata T, Tooyama I, Yamada T, Walker DG, McGeer PL: Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am J Pathol 1993;142:1574-1585.
20. Leveugle B, Spik G, Perl DP, Bouras C, Fillit HM, Hof PR: The iron-binding protein lacto-transferrin is present in pathologic lesions in a variety of neurodegenerative disorders: A comparative immunohistochemical analysis. Brain Res 1994;650:20-31.
21. Patel B, Dunn R, David S: Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J Biol Chem 2000;275:4305-4310.
22. Klomp L, Gitlin J: Expression of the ceruloplasmin gene in the human retina and brain: Implications for a pathogenic model in aceruloplasminemia. Hum Mol Genet 1996;5:1989-1996.
23. Moos T, Morgan E: Transferrin and transferrin receptor function in brain barrier systems. Cell Mol Neurobiol 2000;20:77-95.
24. Crowe A, Morgan EH: Iron and transferrin uptake by brain and cerebrospinal fluid in the rat. Brain Res 1992;592:8-16.
25. Bowman BH, Jansen L, Yang F, Adrian GS, Zhao M, Atherton SS, Buchanan JM, Greene R, Walter C, Herbert DC: Discovery of a brain promoter from the human transferrin gene and its utilization for development of transgenic mice that express human apolipoprotein E alleles. Proc Natl Acad Sci USA 1995;92:12115-12119.
26. Attieh ZK, Mukhopadhyay CK, Seshadri V, Tripoulas NA, Fox PL: Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism. J Biol Chem 1999;274:1116-1123.
27. Burdo JR, Martin J, Menzies SL, Dolan KG, Romano MA, Fletcher RJ, Garrick MD, Garrick LM, Connor JR: Cellular distribution of iron in the brain of the Belgrade rat. Neuroscience 1999;93:1189-1196.
28. Qian ZM, Liao QK, To Y, Ke Y, Tsoi YK, Wang GF, Ho KP: Transferrin-bound and transferrin free iron uptake by cultured rat astrocytes. Cell Mol Biol (Noisy-le-grand) 2000;46:541-548.
29. Dwork AJ, Lawler G, Zybert PA, Durkin M, Osman M, Willson N, Barkai AI: An autoradiographic study of the uptake and distribution of iron by the brain of the young rat. Brain Res 1990;518:31-39.
30. Hulet SW, Powers S, Connor JR: Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains. J Neurol Sci 1999;165:48-55.
31. LaVaute T, Smith S, Cooperman S, Iwai K, Land W, Meyron-Holtz E, Drake S, Miller G, Abu-Asab M, Tsokos M, Switzer R III, Grinberg A, Love P, Tresser N, Rouault T: Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet 2001;27:209-214.
32. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt S, Moynihan J, Paw B, Drejer A, Barut B, Zapata A, Law T, Brugnara C, Lux S, Pinkus G, Pinkus J, Kingsley P, Palis J, Fleming M, Andrews N, Zon L: Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000;403:776-781.
33. Abboud S, Haile D: A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 2000;275:19906-19912.
34. Van Eden ME, Aust SD: Intact human ceruloplasmin is required for the incorporation of iron into human ferritin. Arch Biochem Biophys 2000;381:119-126.
35. Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, Coulthard A, Jackson MJ, Jackson AP, McHale DP, Hay D, Barker WA, Markham AF, Bates D, Curtis A, Burn J: Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001;28:350-354.
36. Double KL, Zecca L, Costi P, Mauer M, Griesinger C, Ito S, Ben-Shachar D, Bringmann G, Fariello RG, Riederer P, Gerlach M: Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins. J Neurochem 2000;75:2583-2589.
37. Zecca L, Tampellini D, Gerlach M, Riederer P, Fariello RG, Sulzer D: Substantia nigra neuromelanin: Structure, synthesis, and molecular behaviour. Mol Pathol 2001;54:414-418.
38. Schipper HM, Bernier L, Mehindate K, Frankel D: Mitochondrial iron sequestration in dopamine-challenged astroglia: Role of heme oxygenase-1 and the permeability transition pore. J Neurochem 1999;72:1802-1811.
39. Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S, Trottier Y, Kish S, Faucheux B, Trouillas P, Authier F, Durr A, Mandel J, Vescovi A, Pandolfo M, Koenig M: Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 1997;6:1771-1780.
40. Koutnikova H, Campuzano V, Foury F, Dolle P, Cazzalini O, Koenig M: Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet 1997;16:345-351.
41. Priller J, Scherzer C, Faber P, MacDonald M, Young A: Frataxin gene of Friedreich's ataxia is targeted to mitochondria. Ann Neurol 1997;42:265-269.
42. Dhe-Paganon S, Shigeta R, Chi Y, Ristow M, Shoelson S: Crystal structure of human frataxin. J Biol Chem 2000;275:30753-30756.
43. Roy C, Andrews N: Recent advances in disorders of iron metabolism: Mutations, mechanisms and modifiers. Hum Mol Genet 2001;10:2181-2186.
44. Sastry S, Arendash GW: Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex. Neuroscience 1995;67:649-666.
45. Maines M: The heme oxygenase system and its functions in the brain. Cell Mol Biol (Noisy-le-grand) 2000;46:573-585.
46. Calabrese V, Scapagnini G, Ravagna A, Fariello RG, Giuffrida Stella AM, Abraham NG: Regional distribution of heme oxygenase, HSP70, and glutathione in brain: Relevance for endogenous oxidant/antioxidant balance and stress tolerance. J Neurosci Res 2002;68:65-75.
47. Poss K, Tonegawa S: Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 1997;94:10919-10924.
48. Mehindate K, Sahlas DJ, Frankel D, Mawal Y, Liberman A, Corcos J, Dion S, Schipper HM: Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: Implications for multiple sclerosis. J Neurochem 2001;77:1386-1395.
49. Bidmon HJ, Emde B, Oermann E, Kubitz R, Witte OW, Zilles K: Heme oxygenase-1 (HSP-32) and heme oxygenase-2 induction in neurons and glial cells of cerebral regions and its relation to iron accumulation after focal cortical photothrombosis. Exp Neurol 2001;168:1-22.
50. Ferris CD, Jaffrey SR, Sawa A, Takahashi M, Brady SD, Barrow RK, Tysoe SA, Wolosker H, Baranano DE, Dore S, Poss KD, Snyder SH: Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1999;1:152-157.
51. Bastin J, Jones M, O'Callaghan C, Schimanski L, Mason D, Townsend A: Kupffer cell staining by an HFE-specific monoclonal antibody: Implications for hereditary haemochromatosis. Br J Haematol 1998;103:931-941.
52. Rouault T: Iron on the brain. Nat Genet 2001;28:299-300.
53. Coburn B: Neurodegeneration: Iron weighs in. Clin Genet 2001;60:267-269.
54. Chiueh CC: Iron overload, oxidative stress, and axonal dystrophy in brain disorders. Pediatr Neurol 2001;25:138-147.
55. Hirsch E, Faucheux B: Iron metabolism and Parkinson's disease. Mov Disord 1998;13(suppl 1):39-45.
56. Castellani RJ, Siedlak SL, Perry G, Smith MA; Sequestration of iron by Lewy bodies in Parkinson's disease. Acta Neuropathol (Berl) 2000;100:111-114.
57. Hashimoto M, Hsu LJ, Xia Y, Takeda A, Sisk A, Sundsmo M, Masliah E: Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. Neuroreport 1999;10:717-721.
58. Ihara Y, Chuda M, Kuroda S, Hayabara T: Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: Relationship to clinical data. J Neurol Sci 1999;170:90-95.
59. Miyajima H, Fujimoto M, Kohno S, Kaneko E, Gitlin JD: CSF abnormalities in patients with aceruloplasminemia. Neurology 1998;51:1188-1190.
60. Yoshida K, Kaneko K, Miyajima H, Tokuda T, Nakamura A, Kato M, Ikeda S: Increased lipid peroxidation in the brains of aceruloplasminemia patients. J Neurol Sci 2000;175:91-95.
61. McNaught KS, Olanow CW, Halliwell B, Isacson O, Jenner P: Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat Rev Neurosci 2001;2:589-594.
62. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR: Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 1998;158:47-52.
63. Connor JR, Menzies SL, St Martin SM, Mufson EJ: A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 1992;31:75-83.
64. Mantyh PW, Ghilardi JR, Rogers S, DeMaster E, Allen CJ, Stimson ER, Maggio JE: Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J Neurochem 1993;61:1171-1174.
65. Rogers JT, Leiter LM, McPhee J, Cahill CM, Zhan SS, Potter H, Nilsson LN: Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences. J Biol Chem 1999;274:6421-6431.
66. Beard J, Connor J, Jones B: Brain iron: Location and function. Prog Food Nutr Sci 1993;17:183-221.
67. Beard J, Connor J, Jones B: Iron in the brain. Nutr Rev 1993;51:157-170.
68. Smith MA, Harris PL, Sayre LM, Perry G: Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 1997;94:9866-9868.
69. Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA: In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals. J Neurochem 2000;74:270-279.
70. Schipper HM: Heme oxygenase-1: Role in brain aging and neurodegeneration. Exp Gerontol 2000;35:821-830.
71. Jefferies WA, Food MR, Gabathuler R, Rothenberger S, Yamada T, Yasuhara O, McGeer PL: Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin. Brain Res 1996;712:122-126.
72. Dobson J: On the structural form of iron in ferritin cores associated with progressive supranuclear palsy and Alzheimer's disease. Cell Mol Biol (Noisy-le-grand) 2001;47(Online Pub):OL49-OL50.
73. Dobson J: Nanoscale biogenic iron oxides and neurodegenerative disease. FEBS Lett 2001;496:1-5.
74. Smith MA, Wehr K, Harris PL, Siedlak SL, Connor JR, Perry G: Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res 1998;788:232-236.
75. Kim DK, Seo MY, Lim SW, Kim S, Kim JW, Carroll BJ, Kwon DY, Kwon T, Kang SS: Serum melanotransferrin, p97 as a biochemical marker of Alzheimer's disease. Neuropsychopharmacology 2001;25:84-90.
76. Ujiie M, Dickstein DL, Jefferies WA: p97 as a biomarker for Alzheimer disease. Front Biosci 2002;7:E42-E47.
77. Double KL, Gerlach M, Youdim MB, Riederer P: Impaired iron homeostasis in Parkinson's disease. J Neural Transm Suppl 2000;60:37-58.
78. Bartzokis G, Cummings J, Perlman S, Hance D, Mintz J: Increased basal ganglia iron levels in Huntington disease. Arch Neurol 1999;56:569-574.
79. Bartzokis G, Cummings J, Markham C, Marmarelis P, Treciokas L, Tishler T, Marder S, Mintz J: MRI evaluation of brain iron in earlier and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 1999;17:213-222.
80. Good PF, Olanow CW, Perl DP: Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: A LAMMA study. Brain Res 1992;593:343-346.
81. Fernandez-Gonzalez A, Perez-Otano I, Morgan JI: MPTP selectively induces haem oxygenase-1 expression in striatal astrocytes. Eur J Neurosci 2000;12:1573-1583.
82. Faucheux BA, Nillesse N, Damier P, Spik G, Mouatt-Prigent A, Pierce A, Leveugle B, Kubis N, Hauw JJ, Agid Y: Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proc Natl Acad Sci USA 1995;92:9603-9607.
83. Lee PL, Gelbart T, West C, Halloran C, Sipe JC, Beutler E: Mutations in iron-regulatory protein 2 (IRP2) and lack of association with sporadic Parkinson's disease. Mov Disord 2002, in press.
84. Boll MC, Sotelo J, Otero E, Alcaraz-Zubeldia M, Rios C: Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease. Neurosci Lett 1999;265:155-158.
85. Lee PL, Halloran C, Beutler E: Polymorphisms in the transferrin 5′ flanking region associated with differences in total iron binding capacity: Possible implications in iron homeostasis. Blood Cells Mol Dis 2001;27:539-548.
86. Schwarz J, Weis S, Kraft E, Tatsch K, Bandmann O, Mehraein P, Vogl T, Oertel WH: Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 1996;60:98-101.
87. Burn DJ, Jaros E: Multiple system atrophy: Cellular and molecular pathology. Mol Pathol 2001;54:419-426.
88. Vymazal J, Righini A, Brooks RA, Canesi M, Mariani C, Leonardi M, Pezzoli G: T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: Relation to iron content. Radiology 1999;211:489-495.
89. Campuzano V, Montermini L, Molto M, Pianese L, Cossee M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A: Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996;271:1423-1427.
90. Bradley JL, Blake JC, Chamberlain S, Thomas PK, Cooper JM, Schapira AH: Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum Mol Genet 2000;9:275-282.
91. Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P: Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet 1997;17:215-217.
92. Miyajima H, Kohno S, Takahashi Y, Yonekawa O, Kanno T: Estimation of the gene frequency of aceruloplasminemia in Japan. Neurology 1999;53:617-619.
93. Tajima K, Kawanami T, Nagai R, Horiuchi S, Kato T: Hereditary ceruloplasmin deficiency increases advanced glycation end products in the brain. Neurology 1999;53:619-622.
94. Galvin JE, Giasson B, Hurtig HI, Lee VM, Trojanowski JQ: Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology. Am J Pathol 2000;157:361-368.
95. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ: A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001;28:345-349.
96. Kato J, Fujikawa K, Kanda M, Fukuda N, Sasaki K, Takayama T, Kobune M, Takada K, Takimoto R, Hamada H, Ikeda T, Niitsu Y: A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet 2001;69:191-197.
97. Bakshi R, Benedict RH, Bermel RA, Caruthers SD, Puli SR, Tjoa CW, Fabiano AJ, Jacobs L: T2 hypointensity in the deep gray matter of patients with multiple sclerosis: A quantitative magnetic resonance imaging study. Arch Neurol 2002;59:62-68.
98. Dallman PR, Beutler E, Finch CA: Effects of iron deficiency exclusive of anaemia. Br J Haematol 1978;40:179-184.
99. Pollitt E, Leibel RL: Iron deficiency and behavior. J Pediatr 1976;88:372-381.
100. Walter T, De Andraca I, Chadud P, Perales CG: Iron deficiency anemia: Adverse effects on infant psychomotor development. Pediatrics 1989;84:7-17.
101. Shukla A, Agarwal KN, Shukla GS: Latent iron deficiency alters gamma-aminobutyric acid and glutamate metabolism in rat brain. Experientia 1989;45:343-345.
102. Shukla A, Agarwal KN, Chansuria JP, Taneja V: Effect of latent iron deficiency on 5-hydroxytryptamine metabolism in rat brain. J Neurochem 1989;52:730-735.
103. Stoebner R, Kiser R, Alperin JB: Iron deficiency anemia and papilledema. Rapid resolution with oral iron therapy. Am J Dig Dis 1970;15:919-922.
104. Beutler E, Fairbanks V: The effects of iron deficiency; in Jacobs A, Worwood M (eds): Iron in Biochemistry and Medicine II. New York, Academic Press, 1980, pp 393-425.
105. Oski FA, Honig AS: The effects of therapy on the developmental scores of iron-deficient infants. J Pediatr 1978;92:21-25.
106. Chen Q, Connor JR, Beard JL: Brain iron, transferrin and ferritin concentrations are altered in developing iron-deficient rats. J Nutr 1995;125:1529-1535.
107. Felt BT, Lozoff B: Brain iron and behavior of rats are not normalized by treatment of iron deficiency anemia during early development. J Nutr 1996;126:693-701.
108. de Deungria M, Rao R, Wobken JD, Luciana M, Nelson CA, Georgieff MK: Perinatal iron deficiency decreases cytochrome c oxidase (CytOx) activity in selected regions of neonatal rat brain. Pediatr Res 2000;48:169-176.
109. Moos T, Trinder D, Morgan EH: Cellular distribution of ferric iron, ferritin, transferrin and divalent metal transporter 1 (DMT 1) in substantia nigra and basal ganglia of normal and beta2 microglobulin deficient mouse brain. Cell Mol Biol (Noisy-le-grand) 2000;46:549-561.
110. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP: Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000;54:1698-1700.
111. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ: MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001;56:263-265.